Case Reports
[Eye toxicity of antimalarial agents]
[Article in
Spanish]
Affiliations
- PMID: 12090061
Item in Clipboard
Case Reports
[Eye toxicity of antimalarial agents]
[Article in
Spanish]
An Med Interna.
2002 Apr.
Abstract
We relate the evolution of a patient with Systemic Lupus Erythematosus with mucocutaneous, hematological, joint and renal expression. The skin lesions were treated with Chloroquine and Hydroxychloroquine and severe ocular toxicity related with antimalarials agent was developed. We revised the antimalarials use in Rheumatology, their utility, doses, adverse events and risk factors as cumulate doses, ideal daily doses, renal function and ophthalmological reviews recommendations.
Similar articles
-
Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.J Am Optom Assoc. 1993 Nov;64(11):787-97. J Am Optom Assoc. 1993. PMID: 8120333 Review.
-
Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.J Rheumatol. 2011 Dec;38(12):2504-8. doi: 10.3899/jrheum.110686. Epub 2011 Oct 15. J Rheumatol. 2011. PMID: 22002012 Review.
-
Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.Arthritis Rheum. 1998 Apr;41(4):744-5. doi: 10.1002/1529-0131(199804)41:4<744::AID-ART26>3.0.CO;2-F. Arthritis Rheum. 1998. PMID: 9550488 No abstract available.
-
Ocular toxicity of antimalarial drugs. Long-term follow-up.Am J Ophthalmol. 1968 Oct;66(4):738-44. doi: 10.1016/0002-9394(68)91300-7. Am J Ophthalmol. 1968. PMID: 5729592 No abstract available.
-
Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.J Med Assoc Thai. 2007 Jan;90(1):52-8. J Med Assoc Thai. 2007. PMID: 17621733